253 related articles for article (PubMed ID: 11115538)
21. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
[TBL] [Abstract][Full Text] [Related]
22. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.
Ogata H; Chinen T; Yoshida T; Kinjyo I; Takaesu G; Shiraishi H; Iida M; Kobayashi T; Yoshimura A
Oncogene; 2006 Apr; 25(17):2520-30. PubMed ID: 16474852
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2.
Guo GH; Tan DM; Zhu PA; Liu F
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):59-64. PubMed ID: 19208517
[TBL] [Abstract][Full Text] [Related]
24. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG
J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722
[TBL] [Abstract][Full Text] [Related]
25. [Gene expression of TGF-beta1 and its type II receptor in hepatocellular carcinoma].
Liu C; Chen S; Ou Q
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):740-2. PubMed ID: 11829941
[TBL] [Abstract][Full Text] [Related]
26. HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1.
Shin JY; Hur W; Wang JS; Jang JW; Kim CW; Bae SH; Jang SK; Yang SH; Sung YC; Kwon OJ; Yoon SK
Exp Mol Med; 2005 Apr; 37(2):138-45. PubMed ID: 15886528
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.
Kang Y; Prentice MA; Mariano JM; Davarya S; Linnoila RI; Moody TW; Wakefield LM; Jakowlew SB
Exp Lung Res; 2000 Dec; 26(8):685-707. PubMed ID: 11195465
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
[TBL] [Abstract][Full Text] [Related]
29. Corticosteroids stimulate selectively transforming growth factor (TGF)-beta receptor type III expression in transdifferentiating hepatic stellate cells.
Wickert L; Abiaka M; Bolkenius U; Gressner AM
J Hepatol; 2004 Jan; 40(1):69-76. PubMed ID: 14672616
[TBL] [Abstract][Full Text] [Related]
30. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.
Harada K; Shiota G; Kawasaki H
Liver; 1999 Aug; 19(4):318-25. PubMed ID: 10459631
[TBL] [Abstract][Full Text] [Related]
32. Transfection of the type II TGF-beta receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype.
MacKay SL; Auffenberg T; Tannahill CL; Ksontini R; Josephs MD; Nowak M; Moldawer LL; Copeland EM
Ann Surg; 1998 Jun; 227(6):781-9. PubMed ID: 9637541
[TBL] [Abstract][Full Text] [Related]
33. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.
Wang J; Sun L; Myeroff L; Wang X; Gentry LE; Yang J; Liang J; Zborowska E; Markowitz S; Willson JK
J Biol Chem; 1995 Sep; 270(37):22044-9. PubMed ID: 7665626
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.
Dzieran J; Fabian J; Feng T; Coulouarn C; Ilkavets I; Kyselova A; Breuhahn K; Dooley S; Meindl-Beinker NM
PLoS One; 2013; 8(8):e72252. PubMed ID: 23991075
[TBL] [Abstract][Full Text] [Related]
35. Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells.
Jiang L; Lai YK; Zhang JF; Chan CY; Lu G; Lin MC; He ML; Li JC; Kung HF
World J Gastroenterol; 2012 May; 18(17):2035-42. PubMed ID: 22563190
[TBL] [Abstract][Full Text] [Related]
36. The level of caveolin-1 expression determines response to TGF-β as a tumour suppressor in hepatocellular carcinoma cells.
Moreno-Càceres J; Caballero-Díaz D; Nwosu ZC; Meyer C; López-Luque J; Malfettone A; Lastra R; Serrano T; Ramos E; Dooley S; Fabregat I
Cell Death Dis; 2017 Oct; 8(10):e3098. PubMed ID: 29022911
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers.
Bedossa P; Peltier E; Terris B; Franco D; Poynard T
Hepatology; 1995 Mar; 21(3):760-6. PubMed ID: 7875675
[TBL] [Abstract][Full Text] [Related]
38. Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA.
Inagaki M; Moustakas A; Lin HY; Lodish HF; Carr BI
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5359-63. PubMed ID: 8389483
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
[TBL] [Abstract][Full Text] [Related]
40. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
